Younossi, Z. M., Stepanova, M., Sulkowski, M., Naggie, S., Henry, L., & Hunt, S. (2016). Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus. Journal of Viral Hepatitis, 23(11), 857. https://doi.org/10.1111/jvh.12554
Chicago Style (17th ed.) CitationYounossi, Z. M., M. Stepanova, M. Sulkowski, S. Naggie, L. Henry, and S. Hunt. "Sofosbuvir and Ledipasvir Improve Patient-reported Outcomes in Patients Co-infected with Hepatitis C and Human Immunodeficiency Virus." Journal of Viral Hepatitis 23, no. 11 (2016): 857. https://doi.org/10.1111/jvh.12554.
MLA (9th ed.) CitationYounossi, Z. M., et al. "Sofosbuvir and Ledipasvir Improve Patient-reported Outcomes in Patients Co-infected with Hepatitis C and Human Immunodeficiency Virus." Journal of Viral Hepatitis, vol. 23, no. 11, 2016, p. 857, https://doi.org/10.1111/jvh.12554.